Adjunctive benzodiazepine treatment of hospitalized schizophrenia patients in Asia from 2001 to 2008

International Journal of Neuropsychopharmacology

Volumn 14, Issue 6, 2011, Pages 735-745

  Tor, Phern Chern ^a   Ng, Tze Pin ^a   Yong, Kian Hui ^b   Sim, Kang ^b   Xiang, Yu Tao ^c,d   Wang, Chuan Yue ^c   Lee, Edwin Ho Ming ^d   Fujii, Senta ^e   Yang, Shu Yu ^f   Chong, Mian Yoon ^g   Ungvari, Gabor S ^h   Si, Tianmei ⁱ   He, Yan Ling ^j   Chung, Eun Kee ^k   Chee, Kok Yoon ^l   Trivedi, Jintendra ^m   Udomratn, Pichet ⁿ   Shinfuku, Naotaka ^o   Kua, Ee Heok ^a   Tan, Chay Hoon ^a   Sartorius, Norman ^p   Baldessarini, Ross J ^q   more..

^a NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^b INSTITUTE OF MENTAL HEALTH   (Singapore)

^c CAPITAL MEDICAL UNIVERSITY   (China)

^d CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^e Hyogo Institute for Traumatic Stress   (Japan)

^f TAIPEI CITY HOSPITAL   (Taiwan)

^g CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^h UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

ⁱ PEKING UNIVERSITY SIXTH HOSPITAL   (China)

^j SHANGHAI MENTAL HEALTH CENTER   (China)

^k Seoul National University Hospital   (South Korea)

^l HOSPITAL KUALA LUMPUR   (Malaysia)

^m KING GEORGE'S MEDICAL UNIVERSITY   (India)

ⁿ PRINCE OF SONGKLA UNIVERSITY   (Thailand)

^o SEINAN GAKUIN UNIVERSITY   (Japan)

^p UNIVERSITY OF GENEVA   (Switzerland)

^q MCLEAN HOSPITAL   (United States)

more..

Author keywords

Adverse effects; antipsychotics; Asian; benzodiazepines; polytherapy; schizophrenia

Indexed keywords

DIAZEPAM;

ADULT; ARTICLE; ASIA; CHINA; CROSS-SECTIONAL STUDY; DELUSION; FEMALE; HALLUCINATION; HOSPITALIZATION; HUMAN; JAPAN; KOREA; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MENTAL PATIENT; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK; SCHIZOPHRENIA; SINGAPORE; STUDY DESIGN; TAIWAN; THAILAND;

ADULT; AGED; ASIA; BENZODIAZEPINES; CROSS-SECTIONAL STUDIES; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG THERAPY, COMBINATION; FEMALE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; PSYCHOTROPIC DRUGS; SCHIZOPHRENIA; STATISTICS AS TOPIC; YOUNG ADULT;

EID: 79958863366     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S146114571000163X     Document Type: Article

References (81)

1. An FR, Xiang YT, Wang CY, Zhang GP, et al. (2010). Change of psychotropic drug prescription for schizophrenia in a psychiatric institution in Beijing, China between 1999 and 2008. International Journal of Clinical Pharmacology and Therapeutics 48, 270-274.
2. APA (1997). Practice Guidelines for the Treatment of Patients with Schizophrenia. Washington, DC: American Psychiatric Press.
3. Ashton H (1994a). Guidelines for the rational use of benzodiazepines. When and what to use. Drugs 48, 25-40.
4. Ashton H (1994b). The treatment of benzodiazepine dependence. Addiction 89, 1535-1541. (Pubitemid 24343917)
5. Ashton H (2005). The diagnosis and management of benzodiazepine dependence. Current Opinion in Psychiatry 18, 249-255. (Pubitemid 40586107)
6. Averill PM, Reas DL, Shack A, Shah NN, et al. (2004). Is schizoaffective disorder a stable diagnostic category: a retrospective examination. Psychiatry Quarterly 75, 215-227. (Pubitemid 38881695)
7. Baranchuk A, Simpson CS, Methot M, Gibson K, et al. (2008). Corrected QT interval prolongation after an overdose of escitalopram, morphine, oxycodone, zopiclone and benzodiazepines. Canadian Journal of Cardiology 24, e38-e40.
8. Barnas C, Whitworth AB, Fleischhacker WW (1993). Are patterns of benzodiazepine use predictable? A follow-up study of benzodiazepine users. Psychopharmacology (Berlin) 111, 301-305. (Pubitemid 23165259)
9. Basan A, Kissling W, Leucht S (2004). Valproate as an adjunct to antipsychotics for schizophrenia: a systematic review of randomized trials. Schizophrenia Research 70, 33-37. (Pubitemid 38916625)
10. Bhoopathi PS, Soares-Weiser K (2006). Benzodiazepines for neuroleptic-induced tardive dyskinesia. Cochrane Database of Systematic Reviews. Issue 3. Art. No. CD000205.
11. Bitter I, Chou JC, Ungvari GS, Tang WK, et al. (2003). Prescribing for inpatients with schizophrenia: an international multi-center comparative study. Pharmacopsychiatry 36, 143-149. (Pubitemid 37041334)
12. Bobes J, Fillat O, Arango C (2009). Violence among schizophrenia out-patients compliant with medication: prevalence and associated factors. Acta Psychiatrica Scandinavica 119, 218-225.
13. Bond WS (1991). Ethnicity and psychotropic drugs. Clinical Pharmacology 10, 467-470.
14. Bondolfi G, Rubin C, Bryois C, Eap CB (1997). Galactorrhoea induced by a pharmacodynamic interaction between citalopram, alprazolam and tramadol: a case report. Therapie 52, 76-77. (Pubitemid 27160425)
15. Brunette M, Noordsy D, Xie H, Drake R (2003a). Benzodiazepine use and abuse among patients with severe mental illness and co-occurring substance use disorders. Psychiatric Services 54, 1395.
16. Brunette MF, Noordsy DL, Xie H, Drake RE (2003b). Benzodiazepine use and abuse among patients with severe mental illness and co-occurring substance use disorders. Psychiatric Services 54, 1395-1401. (Pubitemid 37220041)
17. Centorrino F, Ventriglio A, Vincenti A, Talamo A, et al. (2010). Changes in medication practices for hospitalized psychiatric patients: 2009 vs. 2004. Human Psychopharmacology 25, 179-186.
18. Chen ML (2006). Ethnic or racial differences revisited: impact of dosage regimen and dosage form on pharmacokinetics and pharmacodynamics. Clinical Pharmacokinetics 45, 957-964.
19. Chen YR, Swann AC, Johnson BA (1998). Stability of diagnosis in bipolar disorder. Journal of Nervous and Mental Disorders 186, 17-23. (Pubitemid 28129089)
20. Chong MY, Tan CH, Fujii S, Yang SY, et al. (2004). Antipsychotic drug prescription for schizophrenia in East Asia: rationale for change. Psychiatry and Clinical Neurosciences 58, 61-67. (Pubitemid 38200373)
21. Chouinard G (2004). Issues in the clinical use of benzodiazepines: potency, withdrawal, and rebound. Journal of Clinical Psychiatry 65 (Suppl. 5), 7-12.
22. Citrome L (2009). Adjunctive lithium and anticonvulsants for the treatment of schizophrenia: what is the evidence? Expert Review of Neurotherapies 9, 55-71.
23. Clark RE, Xie H, Brunette MF (2004). Benzodiazepine prescription practices and substance abuse in persons with severe mental illness. Journal of Clinical Psychiatry 65, 151-155.
24. Crockford D (2005). Re: Lorazepam-induced prolongation of the QT interval in a patient with schizoaffective disorder and complete AV block. Canadian Journal of Psychiatry 50, 184-185; author reply 185. (Pubitemid 40515974)
25. Dunbar GC, Perera MH, Jenner FA (1989). Patterns of benzodiazepine use in Great Britain as measured by a general population survey. British Journal of Psychiatry 155, 836-841. (Pubitemid 20086782)
26. Ekedahl A, Lidbeck J, Lithman T, Noreen D, et al. (1993). Benzodiazepine prescribing patterns in a high-prescribing Scandinavian community. European Journal of Clinical Pharmacology 44, 141-146. (Pubitemid 23047749)
27. Fang SY, Chen CY, Chang IS, Wu EC, et al. (2009). Predictors of the incidence and discontinuation of long-term use of benzodiazepines: a population-based study. Drug and Alcohol Dependence 104, 140-146.
28. FDA (Taiwan) (2009). Guidelines for benzodiazepine usage in sedation and hypnosis. Food and Drug Administration, Taiwan.
29. Gaillard R, Ouanas A, Spadone C, Llorca PM, et al. (2006). Benzodiazepines and schizophrenia, a review of the literature. Encephale 32, 1003-1010. (Pubitemid 46061275)
30. Gardner DM, Murphy AL, O'Donnell H, CentorrinoF, et al. (2010). International consensus study of antipsychotic dosing. American Journal of Psychiatry 167, 686-693.
31. Gillies D, Beck A, McCloud A, Rathbone J (2005). Benzodiazepines alone or in combination with antipsychotic drugs for acute psychosis. Cochrane Database of Systematic Reviews. Issue 19(4). Art. No. CD003079.
32. Goodnick PJ, Jerry J, Parra F (2002). Psychotropic drugs and the ECG: focus on the QTc interval. Expert Opinion in Pharmacotherapies 3, 479-498. (Pubitemid 34520859)
33. Gorgels WJ, Oude Voshaar RC, Mol AJ, van de Lisdonk EH, et al. (2006). Predictors of discontinuation of benzodiazepine prescription after sending a letter to long-term benzodiazepine users in family practice. Family Practice 23, 65-72. (Pubitemid 43174688)
34. Haw C, Stubbs J (2007). Benzodiazepines - a necessary evil? A survey of prescribing at a specialist UK psychiatric hospital. Journal of Psychopharmacology 21, 645-649. (Pubitemid 47472729)
35. Hermos JA, Young MM, Lawler EV, Stedman MR, et al. (2005). Characterizations of long-term anxiolytic benzodiazepine prescriptions in veteran patients. Journal of Clinical Psychopharmacology 25, 600-604. (Pubitemid 41669059)
36. Hussain MZ, Harinath M, Murphy J (1972). Tranquillizer-induced galactorrhea. Canadian Medical Association Journal 106, 1107-1108.
37. Inagaki A, Inada T, Fujii Y (1999). Equivalent Dose of Psychotropics. Tokyo: Seiwa Shoten.
38. Isacson D (1997). Long-term benzodiazepine use: factors of importance and the development of individual use patterns over time - a 13-year follow-up in a Swedish community. Social Sciences and Medicine 44, 1871-1880. (Pubitemid 27246201)
39. Joyal CC, Gendron C, Cote G (2008). Nature and frequency of aggressive behaviours among long-term inpatients with schizophrenia: a 6-month report using the modified overt aggression scale. Canadian Journal of Psychiatry 53, 478-481.
40. Kane JM, Aguglia E, Altamura AC, Ayuso Gutierrez JL, et al. (1998). Guidelines for depot antipsychotic treatment in schizophrenia. European Neuropsychopharmacology Consensus Conference in Siena, Italy. European Neuropsychopharmacology 8, 55-66. (Pubitemid 28012861)
41. Kato R, Watanabe R, Miki H, Ijiri Y, et al. (2009). Does the sedative agent, JM-1232(x) cause QT prolongation with subsequent torsades de pointes? Life Sciences 85, 737-741.
42. Kopecek M, Bares M, Horacek J, Mohr P (2006). Low-dose risperidone augmentation of antidepressants or anxiolytics is associated with hyperprolactinemia. Neuroendocrinology Letters 27, 803-806. (Pubitemid 46138643)
43. Lai HY, Hwang SJ, Chen YC, Chen TJ, et al. (2009). Prevalence of the prescribing of potentially inappropriate medications at ambulatory care visits by elderly patients covered by the Taiwanese national health insurance program. Clinical Therapeutics 31, 1859-1870.
44. Lewis DA, Cho RY, Carter CS, Eklund K, et al. (2008). Subunit-selective modulation of GABA type A receptor neurotransmission and cognition in schizophrenia. American Journal of Psychiatry 165, 1585-1593.
45. Magliano L, Fiorillo A, Guarneri M, Marasco C, et al. (2004). Prescription of psychotropic drugs to patients with schizophrenia: an Italian national survey. European Journal of Clinical Pharmacology 60, 513-522. (Pubitemid 39350164)
46. Mauri MC, Regispani F, Beraldo S, Volonteri LS, et al. (2005). Patterns of clinical use of antipsychotics in hospitalized psychiatric patients. Progress in Neuropsychopharmacology and Biological Psychiatry 29, 957-963. (Pubitemid 41080118)
47. Mojtabai R, Olfson M (2010). National trends in psychotropic medication polypharmacy in office-based psychiatry. Archives of General Psychiatry 67, 26-36.
48. Nakao M, Takeuchi T, Yano E (2007). Prescription of benzodiazepines and antidepressants to outpatients attending a Japanese university hospital. International Journal of Clinical Pharmacological Therapies 45, 30-35. (Pubitemid 46343974)
49. Neutel CI (2005). The epidemiology of long-term benzodiazepine use. Internatoinal Review of Psychiatry 17, 189-197. (Pubitemid 40827296)
50. Neutel CI, Walop W, Patten SB (2003). Can continuing benzodiazepine use be predicted? Canadian Journal of Clinical Pharmacology 10, 202-206. (Pubitemid 38181973)
51. Nomura K, Nakao M, Sato M, Yano E (2006). Regular prescriptions for benzodiazepines: a cross-sectional study of outpatients at a university hospital. Internal Medicine 45, 1279-1283. (Pubitemid 44942085)
52. Petitjean S, Ladewig D, Meier CR, Amrein R, et al. (2007). Benzodiazepine prescribing to the Swiss adult population: results from a national survey of community pharmacies. International Clinical Psychopharmacology 22, 292-298. (Pubitemid 47237548)
53. RACGP (2000). Guidelines: Benzodiazepines. The Royal Australian College of General Practitioners.
54. RANZCP (1999). College guidelines for use of benzodiazepines. Practice Guideline no. 5. Psychotropic Drugs Committee, The Royal Australian and New Zealand College of Psychiatrists.
55. Ruiz I, Offermanns J, Lanctot KL, Busto U (1993). Comparative study on benzodiazepine use in Canada and Chile. Journal of Clinical Pharmacology 33, 124-129. (Pubitemid 23089633)
56. Salvatore P, Baldessarini RJ, Tohen M, Khalsa HM, et al. (2009). McLean-Harvard International First-Episode Project: two-year stability of DSM-IV diagnoses in 500 first-episode psychotic disorder patients. Journal of Clinical Psychiatry 70, 458-466.
57. Salvatore P, Baldessarini RJ, Tohen M, Khalsa HM, et al. (in press). McLean-Harvard International First-Episode Project: two-year stability of ICD-10 diagnosis in 500 first-episode psychotic disorder patients. Journal of Clinical Psychiatry.
58. Shinfuku N, Tan CH (2008). Pharmacotherapy for schizophrenic inpatients in East Asia - changes and challenges. International Review of Psychiatry 20, 460-468.
59. Shioiri T, Kita N, Takahashi S (1996). Two cases of alprazolam-induced hyperprolactinemia in patients with panic disorder. International Clinical Psychopharmacology 11, 149-152. (Pubitemid 26194514)
60. Sim K, Su A, Leong JY, Yip K, et al. (2004). High dose antipsychotic use in schizophrenia: findings of the REAP (research on east Asia psychotropic prescriptions) study. Pharmacopsychiatry 37, 175-179. (Pubitemid 38916427)
61. Simon GE, VonKorff M, Barlow W, Pabiniak C, et al. (1996). Predictors of chronic benzodiazepine use in a health maintenance organization sample. Journal of Clinical Epidemiology 49, 1067-1073. (Pubitemid 26319043)
62. Smith GN, MacEwan GW, Ancill RJ, Honer WG, et al. (1992). Diagnostic confusion in treatment-refractory psychotic patients. Journal of Clinical Psychiatry 53, 197-200.
63. Subramaniam M, Pek E, Verma S, Chan YH, et al. (2007). Diagnostic stability 2 years after treatment initiation in the early psychosis intervention programme in Singapore. Australia and New Zealand Journal of Psychiatry 41, 495-500. (Pubitemid 46805633)
64. Swanson JW, Swartz MS, Van Dorn RA, Elbogen EB, et al. (2006). A national study of violent behavior in persons with schizophrenia. Archives of General Psychiatry 63, 490-499.
65. Tan CH, Shinfuku N, Sim K (2008). Psychotropic prescription practices in east Asia: looking back and peering ahead. Current Opinion in Psychiatry 21, 645-650.
66. Taylor D, Paton C, Kapur S (2009). The Maudsley Prescribing Guidelines 10th Edition. Informa Healthcare.
67. Tkachenko NM, Bogdanova EA, Moroz MG, Afonina LI (1984). Use of tranquilizers in the diagnosis of causes of secondary amenorrhea in girls. Akushertvo i ginekologiia 11, 69-71.
68. Tognoni G (1999). Pharmacoepidemiology of psychotropic drugs in patients with severe mental disorders in Italy. European Journal of Clinical Pharmacology 55, 685-690.
69. Valenstein M, Taylor KK, Austin K, Kales HC, et al. (2004). Benzodiazepine use among depressed patients treated in mental health settings. American Journal of Psychiatry 161, 654-661. (Pubitemid 38445509)
70. van Hulten R, Teeuw KB, Bakker A, Leufkens HG (2003). Initial 3-month usage characteristics predict long-term use of benzodiazepines: an 8-year follow-up. European Journal of Clinical Pharmacology 58, 689-694. (Pubitemid 36363298)
71. Volz A, Khorsand V, Gillies D, Leucht S (2007). Benzodiazepines for schizophrenia. Cochrane Database of Systematic Reviews. Issue 24(1). Art No. CD006391.
72. Vorma H, Naukkarinen HH, Sarna SJ, Kuoppasalmi KI (2005). Predictors of benzodiazepine discontinuation in subjects manifesting complicated dependence. Substance Use and Misuse 40, 499-510. (Pubitemid 40464353)
73. Voshaar RO, Gorgels W, Mol A, van Balkom A, et al. (2003). Predictors of relapse after discontinuation of long-term benzodiazepine use by minimal intervention: a 2-year follow-up study. Family Practice 20, 370-372. (Pubitemid 36939661)
74. Weizman A, Tyano S, Wijsenbeek H, Ben David M (1984). High dose diazepam treatment and its effect on prolactin secretion in adolescent schizophrenic patients. Psychopharmacology (Berlin) 82, 382-385. (Pubitemid 14138840)
75. Wheeler A, Kairuz T, Sheridan J, McPhee E (2007). Sedative-hypnotic treatment in an acute psychiatric setting: comparison with best practice guidance. Pharmcology World Sciences 29, 603-610. (Pubitemid 47594164)
76. WHO (2010). ATC/DDD Index 2010. World Health Organization.
77. Woods SW (2003). Chlorpromazine equivalent doses for the newer atypical antipsychotics. Journal of Clinical Psychiatry 64, 663-667. (Pubitemid 36750143)
78. Xiang YT, Weng YZ, Leung CM, Tang WK, et al. (2007a). Clinical and social determinants of long-term use of benzodiazepines and its impact on quality of life of Chinese schizophrenia patients. Pharmacopsychiatry 40, 269-274.
79. Xiang YT, Weng YZ, Leung CM, Tang WK, et al. (2007b). Clinical and social determinants of psychotropic drug prescription for schizophrenia outpatients in China. Progress in Neuropsychopharmacology and Biological Psychiatry 31, 756-760.
80. Yamagiwa T, Amino M, Morita S, Yamamoto R, et al. (2010). A case of torsades de pointes induced by severe QT prolongation after an overdose of eperisone and triazolam in a patient receiving nifedipine. Clinical Toxicology (Philadelphia) 48, 149-152.
81. Ziegenbein M, Kropp S (2004). Lorazepam-induced prolongation of the QT interval in a patient with schizoaffective disorder and complete AV block. Canadian Journal of Psychiatry 49, 414. (Pubitemid 38878679)